While attending the 2023 BIO International Convention, Samsung Biologics, a leading contract development and manufacturing organization (CDMO), revealed details of the company’s future expansion plan to have its new fifth plant operational by April 2025. Recently on June 1, the company fully completed its latest and the world’s largest biomanufacturing plant, Plant 4. The move […]

The post Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025 first appeared on World Pharma Today.